Zai Lab Limited Announces Breakthrough Therapy Designation Granted for Repotrectinib for Treatment of Patients with Ntrk-Positive Tki-Pretreated Advanced Solid Tumors in China

Zai Lab Limited announced that the Center for Drug Evaluation of the National Medical Products Administration granted Breakthrough Therapy Designation for investigational repotrectinib for the...

Related Keywords

Macau ,Hong Kong ,Taiwan ,United States ,China ,Chinese , ,Drug Administration ,Zai Lab ,National Medical Products Administration ,Zai Lab Limited ,Drug Evaluation ,Breakthrough Therapy Designation ,Breakthrough Therapy Designations ,New Drug Application ,Greater China ,Turning Point Therapeutics ,Orphan Drug Designation ,Therapy Designations ,Fast Track Designations ,Turning Point ,Markets ,